Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
מצבים רפואיים
Acute Myeloid Leukemia
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Phoenix Children's Hospital, Phoenix, Arizona, United States
Contact: Principal Investigator (Laura Retson, DO)Arkansas Children's Hospital, Little Rock, Arkansas, United States
Contact: Principal Investigator (Kevin J Bielamowicz, MD)City of Hope, Duarte, California, United States
Contact: Principal Investigator (Lindsey Murphy, MD)Stanford University, Stanford, California, United States
Contact: Principal Investigator (Norman Lacayo)Tanja Gruber (Sub-investigator)Cincinnati Children's Hospital, Cincinnati, Ohio, United States
Contact: Principal Investigator (Jennifer Kamens, MD)Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States
Contact: Principal Investigator (Valerie Brown, MD, PhD)St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Seth Karol, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Spencer Mangum, MD)University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
Contact: Study coordinator (Pediatric HemOnc Main Line) · PedsHemOncResearch@g-groups.wisc.edu · 608-263-6200Contact: Principal Investigator (Rebecca Richards, MD)
מובילי המחקר
Norman Lacayo, MD
Principal Investigator
Stanford Universiy